MarketLens
Sign Up

What Does Full Enrollment Mean for Tiziana Life Sciences

5 months ago
SHARE THIS ON:

What Does Full Enrollment Mean for Tiziana Life Sciences

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•3 weeks ago

Tiziana Life Sciences completes patient visits in Phase 2a MS drug trial

Tiziana Life Sciences completed final patient visits in its 48-patient Phase 2a INFORM-MS trial of intranasal foralumab for non-active secondary progressive MS, moving the program toward data readout.
Stock News•1 months ago

Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study

Immunocore reached its target enrollment in the phase III TEBE-AM study of Kimmtrak in previously treated advanced melanoma, keeping the label-expansion trial on schedule.
Stock News•2 months ago

UTHR Completes Phase III Tyvaso Study Enrollment for Expanded Label

United Therapeutics completed enrollment in its Phase III Tyvaso study for PPF, with top-line results expected in H2 2027.

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

Greg Abel Made Major Additions to Alphabet and Delta Last Quarter While Berkshire Bought Back $4.4 Billion of Its Own Stock. Is This a Buying Signal Investors Should Watch?

Stock News•3 hours ago

Lightbridge (LTBR) CEO on CEG & GOOGL Nuclear Energy Deal, Global Expansion

Stock News•4 hours ago

Apple's Market Value Grew From $350 Billion to $5 Trillion During Tim Cook's 15 Years as CEO. Here's What That Growth Curve Means for Apple's Next Chapter Under John Ternus.

Stock News•5 hours ago

GOOGL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Alphabet Investors of Securities Class Action Lawsuit Deadline on November 30, 2026

Stock News•6 hours ago

PLTR Unique Value in Volatile AI Trade, New NVDA & NBIS Partnerships